UROLEAD has developed key collaborations with Institut Curie to accelerate the characterization of its bladder PDX models.

UROLEAD and the urological department of the Nouvel Hôpital Civil (NHC) of Strasbourg have set up for more than 10 years a strategic partnership for development and histological characterization of urological PDX models. NHC has provided to Urolead more than 900 freshly excised patient tumor samples, after obtention of patient informed consent.

UROLEAD is in close partnership with INSERM for development of RCC PDX models.